Inovio Pharmaceuticals faces an October 30 PDUFA date for INO-3107 with high regulatory risk and only a 5-7 month cash runway. Read why INO stock is a hold.

The city of Springfield is following in the steps of other large employers in filing suit against manufacturers of diabetes ...

Pharmaceutical companies have raised prices on hundreds of drugs so far this month despite federal efforts to rein in drug ...

Jardiance is the brand name for empagliflozin, an SGLT2 inhibitor used in adults with type 2 diabetes, chronic kidney disease ...

The prices of hundreds of prescription medications in the United States are expected to climb in 2026, according to a new industry analysis, raising questions about the effectiveness of recent Trump ...

Medicare beneficiaries could see out-of-pocket prescription drug costs cut by more than half in 2026, according to a new AARP analysis. The savings stem from the first round of drug price negotiations ...

(The Center Square) – Negotiated lower Medicare costs for 10 popular prescription drugs went into effect Thursday. How much those savings will be passed on to Medicare Part D and applicable Advantage ...

Amgen AMGN recently signed a landmark agreement with the Trump administration to lower drug prices in the United States. Through this deal, Amgen addresses the two major concerns that have plagued Big ...

John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. You’re reading the web edition ...

On Friday, President Trump announced that his administration has signed separate drug-pricing agreements with several large-cap drugmakers to lower drug prices in the country. These companies include ...

President Donald Trump says it's the biggest thing to happen to drug pricing. The White House says 9 drug manufacturers have agreed to give Medicaid in all 50 states access to most favored nation ...